Logo image of ALMCE.PA

MON COURTIER ENERGIE GROUPE (ALMCE.PA) Stock Fundamental Analysis

EPA:ALMCE - Euronext Paris - Matif - FR001400H3A0 - Common Stock - Currency: EUR

5.35  -0.05 (-0.93%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to ALMCE. ALMCE was compared to 21 industry peers in the Independent Power and Renewable Electricity Producers industry. While ALMCE seems to be doing ok healthwise, there are quite some concerns on its profitability. ALMCE is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ALMCE had negative earnings in the past year.
ALMCE had a positive operating cash flow in the past year.
ALMCE.PA Yearly Net Income VS EBIT VS OCF VS FCFALMCE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 1M 2M

1.2 Ratios

ALMCE has a Return On Assets of -0.97%. This is in the lower half of the industry: ALMCE underperforms 76.19% of its industry peers.
With a Return On Equity value of -2.03%, ALMCE is not doing good in the industry: 76.19% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -0.97%
ROE -2.03%
ROIC N/A
ROA(3y)8.1%
ROA(5y)N/A
ROE(3y)15.86%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALMCE.PA Yearly ROA, ROE, ROICALMCE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 10 20 30 40

1.3 Margins

ALMCE's Gross Margin of 23.71% is in line compared to the rest of the industry. ALMCE outperforms 42.86% of its industry peers.
In the last couple of years the Gross Margin of ALMCE has declined.
ALMCE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 23.71%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.26%
GM growth 5YN/A
ALMCE.PA Yearly Profit, Operating, Gross MarginsALMCE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 10 20 30

More info and screens

6

2. Health

2.1 Basic Checks

ALMCE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ALMCE remains at a similar level compared to 1 year ago.
Compared to 1 year ago, ALMCE has a worse debt to assets ratio.
ALMCE.PA Yearly Shares OutstandingALMCE.PA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 1M 2M 3M
ALMCE.PA Yearly Total Debt VS Total AssetsALMCE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

An Altman-Z score of 2.73 indicates that ALMCE is not a great score, but indicates only limited risk for bankruptcy at the moment.
ALMCE has a better Altman-Z score (2.73) than 66.67% of its industry peers.
ALMCE has a debt to FCF ratio of 2.76. This is a good value and a sign of high solvency as ALMCE would need 2.76 years to pay back of all of its debts.
The Debt to FCF ratio of ALMCE (2.76) is better than 95.24% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that ALMCE is not too dependend on debt financing.
The Debt to Equity ratio of ALMCE (0.00) is better than 95.24% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 2.76
Altman-Z 2.73
ROIC/WACCN/A
WACC7.78%
ALMCE.PA Yearly LT Debt VS Equity VS FCFALMCE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 2M 4M 6M 8M 10M

2.3 Liquidity

A Current Ratio of 1.72 indicates that ALMCE should not have too much problems paying its short term obligations.
ALMCE's Current ratio of 1.72 is fine compared to the rest of the industry. ALMCE outperforms 66.67% of its industry peers.
ALMCE has a Quick Ratio of 1.72. This is a normal value and indicates that ALMCE is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of ALMCE (1.72) is better than 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.72
Quick Ratio 1.72
ALMCE.PA Yearly Current Assets VS Current LiabilitesALMCE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 5M 10M 15M

More info and screens

6

3. Growth

3.1 Past

ALMCE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -115.63%.
The Revenue has grown by 17.25% in the past year. This is quite good.
ALMCE shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 36.13% yearly.
EPS 1Y (TTM)-115.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-87.4%
Revenue 1Y (TTM)17.25%
Revenue growth 3Y36.13%
Revenue growth 5YN/A
Sales Q2Q%21.26%

3.2 Future

Based on estimates for the next years, ALMCE will show a very strong growth in Earnings Per Share. The EPS will grow by 77.28% on average per year.
The Revenue is expected to grow by 15.41% on average over the next years. This is quite good.
EPS Next Y-50%
EPS Next 2Y77.28%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year8.91%
Revenue Next 2Y15.41%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ALMCE.PA Yearly Revenue VS EstimatesALMCE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 10M 20M 30M
ALMCE.PA Yearly EPS VS EstimatesALMCE.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 0.1 0.2 0.3 0.4

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

ALMCE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 74.20, the valuation of ALMCE can be described as expensive.
ALMCE's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. ALMCE is more expensive than 61.90% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of ALMCE to the average of the S&P500 Index (21.90), we can say ALMCE is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 74.2
ALMCE.PA Price Earnings VS Forward Price EarningsALMCE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50

4.2 Price Multiples

ALMCE's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. ALMCE is more expensive than 61.90% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, ALMCE is valued a bit cheaper than the industry average as 71.43% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 63.78
EV/EBITDA 27.04
ALMCE.PA Per share dataALMCE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

ALMCE's earnings are expected to grow with 77.28% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y77.28%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALMCE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MON COURTIER ENERGIE GROUPE

EPA:ALMCE (7/4/2025, 7:00:00 PM)

5.35

-0.05 (-0.93%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryIndependent Power and Renewable Electricity Producers
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.33%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap19.58M
Analysts84.44
Price Target6.63 (23.93%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.33
Dividend Growth(5Y)N/A
DP-600.49%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 74.2
P/S 0.79
P/FCF 63.78
P/OCF 27.62
P/B 1.96
P/tB 2.67
EV/EBITDA 27.04
EPS(TTM)-0.06
EYN/A
EPS(NY)0.07
Fwd EY1.35%
FCF(TTM)0.08
FCFY1.57%
OCF(TTM)0.19
OCFY3.62%
SpS6.74
BVpS2.73
TBVpS2
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.97%
ROE -2.03%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 23.71%
FCFM 1.24%
ROA(3y)8.1%
ROA(5y)N/A
ROE(3y)15.86%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.26%
GM growth 5YN/A
F-Score5
Asset Turnover1.18
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 2.76
Debt/EBITDA 0.01
Cap/Depr 80.72%
Cap/Sales 1.63%
Interest Coverage N/A
Cash Conversion 149.58%
Profit Quality N/A
Current Ratio 1.72
Quick Ratio 1.72
Altman-Z 2.73
F-Score5
WACC7.78%
ROIC/WACCN/A
Cap/Depr(3y)39.27%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.73%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-115.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-87.4%
EPS Next Y-50%
EPS Next 2Y77.28%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)17.25%
Revenue growth 3Y36.13%
Revenue growth 5YN/A
Sales Q2Q%21.26%
Revenue Next Year8.91%
Revenue Next 2Y15.41%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-101.62%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year60%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y149.84%
FCF growth 3Y-48.05%
FCF growth 5YN/A
OCF growth 1Y231.05%
OCF growth 3Y-31.54%
OCF growth 5YN/A